IOVS JNNP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verma, M. J.
Right arrow Articles by Wakefield, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verma, M. J.
Right arrow Articles by Wakefield, D.
(Investigative Ophthalmology and Visual Science. 1999;40:2465-2470.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Endotoxin-Induced Uveitis is Partially Inhibited by Anti–IL-8 Antibody Treatment

Manju J. Verma, Naofumi Mukaida1, Ute Vollmer–Conna, Kouji Matsushima1, Andrew Lloyd and Denis Wakefield

From the Inflammation Research Unit, School of Pathology, University of New South Wales, Sutherland Centre of Immunology, Sydney, Australia.

PURPOSE. To examine the potential therapeutic effect of a neutralizing anti–IL-8 monoclonal antibody in endotoxin-induced uveitis (EIU) in the rabbit.

METHODS. An anti–IL-8 antibody (WS-4) was injected intravitreal 2 hours before, simultaneously with, or 6 hours after endotoxin challenge in rabbits. Eyes were examined for clinical signs of inflammation, and aqueous humor (AH) was sampled to study cellular infiltration and protein content. Leukocyte subset analysis was performed on Giemsa-stained AH cytospins. Histologic grading of inflammation was performed on hematoxylin-eosin–stained sagittal sections of enucleated eyes. In separate experiments, animals received the anti–IL-8 antibody simultaneously with the endotoxin challenge, before repeated anterior chamber paracentesis was performed (at 6, 12, 24, 48, and 72 hours after injection) to estimate the kinetics and durability of changes in total cell count and protein concentration in AH.

RESULTS. Anti–IL-8 therapy caused a decrease in the clinical and histologic grade of inflammation in EIU. The mean cell count in the AH at the peak of inflammation (24 hours) in eyes receiving endotoxin only was 6419 ± 1165/µl (mean ± SE) compared to 2546 ± 573/µl in rabbits treated simultaneously with 250 µg of anti–IL-8 antibody (P < 0.05). The protein concentration in the AH was not significantly altered by anti–IL-8 treatment. Kinetic analysis of the leukocyte count in the AH demonstrated persistent inhibition of leukocyte accumulation (range, 60%–91% compared to control eyes) by the anti–IL-8 antibody administered simultaneously with endotoxin. This inhibition was sustained for up to 72 hours after injection.

CONCLUSIONS. Anti–IL-8 antibody treatment partially blocks EIU in rabbits. A consistent decrease in the recruitment of polymorphonuclear leukocytes into the anterior chamber was obtained when neutralizing antibody was injected simultaneously with endotoxin. These findings suggest that IL-8 contributes to the chemotactic signal for the recruitment of leukocytes in EIU.




This article has been cited by other articles:


Home page
IOVSHome page
L. J. M. Relvas, C. Bouffioux, B. Marcet, D. Communi, M. Makhoul, M. Horckmans, D. Blero, C. Bruyns, L. Caspers, J.-M. Boeynaems, et al.
Extracellular Nucleotides and Interleukin-8 Production by ARPE Cells: Potential Role of Danger Signals in Blood-Retinal Barrier Activation
Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1241 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
P. Mruthyunjaya, D. Khalatbari, P. Yang, S. Stinnett, R. Tano, P. Ashton, H. Guo, M. Nazzaro, and G. J. Jaffe
Efficacy of Low-Release-Rate Fluocinolone Acetonide Intravitreal Implants to Treat Experimental Uveitis
Arch Ophthalmol, July 1, 2006; 124(7): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Bucolo, S. Cuzzocrea, E. Mazzon, and A. P. Caputi
Effects of Cloricromene, a Coumarin Derivative, on Endotoxin-Induced Uveitis in Lewis Rats
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1178 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Shirvan, M. Kimron, V. Holdengreber, I. Ziv, Y. Ben-Shaul, S. Melamed, E. Melamed, A. Barzilai, and A. S. Solomon
Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy
J. Biol. Chem., December 13, 2002; 277(51): 49799 - 49807.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C Cuello, D Wakefield, and N Di Girolamo
Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis
Br. J. Ophthalmol., March 1, 2002; 86(3): 290 - 295.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. C. Callegan, M. Engelbert, D. W. Parke II, B. D. Jett, and M. S. Gilmore
Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions
Clin. Microbiol. Rev., January 1, 2002; 15(1): 111 - 124.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Lemaitre, B. Thillaye-Goldenberg, M.-C. Naud, and Y. de Kozak
The Effects of Intraocular Injection of Interleukin-13 on Endotoxin-Induced Uveitis in Rats
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2022 - 2030.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology